FDA Commissioner Marty Makary released a statement on X stating that the agency is expected to begin moving against copycat ...

In today’s Pharmaceutical Executive Daily, TrumpRx officially launches, the FDA moves against mass marketing of illegal copycat drugs, and AI emerges as a force multiplier for small and mid-size ...

In a lean biotech environment with aggressive milestones, teams often accept reporting that is “good enough.” But those ...

TrumpRx operationalizes most-favored-nation pricing largely via coupon cards redeemable at pharmacies or through manufacturer ...

President Trump first announced TrumpRx in September, 2025. The announcement came after a period of negotiations with major pharma companies to reduce drug costs in the United States.

Novo Nordisk is debuting its first-Super Bowl commercial to promote its newly launched once-daily Wegovy pill, an oral formulation of semaglutide for adults with obesity or overweight with related ...

In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...

FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...

Veradermics Inc., a late clinical-stage biopharmaceutical company focused on hair restoration, raised $256.3 million in an ...

By giving small and mid-size biotechs access to real-world data and advanced analytics once reserved for large pharma, AI ...

In today’s Pharmaceutical Executive Daily, Susan G. Komen releases its 2026 breast cancer progress outlook, industry leaders ...

SanegeneBio and Genentech entered a global licensing agreement aimed at advancing an RNA interference (RNAi) therapeutic ...